Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP MIDODRINE DIN 02517701

Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: MIDODRINE HYDROCHLORIDE
Available to quote

Health Canada record

Active ingredient(s)MIDODRINE HYDROCHLORIDE 2.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC01CA17 MIDODRINE
Original market date21-Feb-2022
Current status date21-Feb-2022
SourceHealth Canada DPD

Establishment licence of the holder

Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MIDODRINE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
02278677APO-MIDODRINEAPOTEX INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02278685APO-MIDODRINEAPOTEX INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02517728JAMP MIDODRINEJAMP PHARMA CORPORATIONTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02547112M-MIDODRINEMANTRA PHARMA INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02547120M-MIDODRINEMANTRA PHARMA INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02473992MAR-MIDODRINEMARCAN PHARMACEUTICALS INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02473984MAR-MIDODRINEMARCAN PHARMACEUTICALS INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02533200MIDODRINESANIS HEALTH INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02533219MIDODRINESANIS HEALTH INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
01934392AMATINESHIRE PHARMA CANADA ULCTabletMIDODRINE HYDROCHLORIDE 2.5 MGCancelled Post Market
01934406AMATINESHIRE PHARMA CANADA ULCTabletMIDODRINE HYDROCHLORIDE 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
262222021-07-08Abbreviated New Drug Submission (ANDS)

International API supply for MIDODRINE HYDROCHLORIDE

14 active FDA Drug Master Files.

Request a quote for JAMP MIDODRINE

How to read a Canadian DIN record